Clinical Trial Update: Compare the Efficacy and Safety of Beta-Glucan as Add-On to Statin in Subjects With Hyperlipidemia. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating beta-glucan added to statin therapy for hyperlipidemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hyperlipidemias

Drugs mentioned

• Beta Glucan (beta-glucan)
• Statin (statin)

Snippet

Sponsor: Montreal Heart Institute | Conditions: Hyperlipidemias | Phase 2 | Status: COMPLETED | Results posted: 2024-01-16